FDA "proposed" Public Disclosure
The FDA and key staff therein have SIGNIFICANT financial ties to the brand name drug industry. Therefore, when taking FDA approved prescription drugs you will, most likely, be paying the highest prices in the world for medications with unknown, untested or unlisted adverse drug reactions. The financial relationship between the FDA and the brand name drug industry may be harmful to your health up to and including death.
Why Would The FDA Support
A Ban
On U.S. Citizens
Importing Lower Cost
Canadian Medications?
by Gary W. Lawson, Ph.D., DPA
Since 1992, the FDA has been collecting money from the brand name pharmaceutical manufacturers. The FDA now collects nearly $200,000,000 per year from the drug industry. This money represents more than 51% of the FDA's new drug approval division budget and nearly 2,000 of the FDA's 10,000 employees are dependent on the continuation of the drug industry money for their employment. It is clear that the FDA is now financially beholding to the drug industry, and stopping the influx of lower cost Canadian medications is a top FDA priority.
Discrediting Canadian medication importation is the FDA's attempt to make their new financial benefactors "happy". The drug industry has financial leverage over both Houses of Congress, the White House, the National Institute of Health, medical societies on both sides of the border, and now, the FDA has fallen.
FDA comes to the drug industry’s rescue! To protect the drug industry's profits, and stop Americans from getting lower cost Canadian medications, the FDA used a previously ignored 60 year-old law that said only medications with the FDA “ink stamp” on them could be imported into the United States. The FDA knows that medications coming from other industrialized nations are exactly the same, and that nearly every other industrialized country in the world has an equivalent to the FDA, but no other country has the FDA. Thus, getting an FDA “ink stamp” on medications coming from any other country is impossible. With no FDA ink stamp, the medications cannot be legally imported into the U.S. and the pharmaceutical manufacturers can continue their monopolistic price gouging, and make no mistake, the drug companies are exempt from this ink stamp restriction.
FDA literally uses previously ignored “ink stamp law” to protect drug industry’s U.S. monopoly and force American consumers to pay much higher prices.
Armed with lies, exaggerations, misrepresentations and deceptions, since 2002, the FDA used a scare tactics media campaign to curtail the re-importation of lower cost medications. In conjunction with the wishes and desires of the brand name drug industry, FDA's financial supporter, the FDA emphasized the dangers of obtaining Canadian medications.
Learning that a U.S. public regulatory agency is exchanging money for favors is inconceivable. However, the unfortunate fact of this unethical partnership is now the FDA is helping one of the world's most predatory and profiteering industries steal from America's most vulnerable. The FDA in partnership with the brand name drug industry is stealing from the sick, poor, elderly and disabled in a cold, heartless, calculated and premeditated manner simply to make the very rich even richer.
FDA switched from protecting consumers to protecting the insatiable greed and financial interests of the pharmaceutical companies they are mandated to regulate.
YOU Can Make A Difference!
- If you want to help, please click on "Now What" here or on the left hand column.
- Tell your friends, family, co-workers and neighbors about the problem. Ask them to get involved.
- Ask your local media (ie. newspapers, magazines, radio, television stations) to cover the issue.
- Speak to your local politicians and ask them to announce "No Confidence" in the federal government's ability to protect and safeguard U.S. citizens regarding prescription drugs, and announce the "No Confidence" referendum to the media.